A phase II study of apatinib in patients with recurrent epithelial ovarian cancer.
Miao M, Deng G, Luo S, Zhou J, Chen L, Yang J, He J, Li J, Yao J, Tan S, Tang J.
Miao M, et al. Among authors: zhou j.
Gynecol Oncol. 2018 Feb;148(2):286-290. doi: 10.1016/j.ygyno.2017.12.013. Epub 2017 Dec 18.
Gynecol Oncol. 2018.
PMID: 29248198
Clinical Trial.